Genomics England Blog

Data & Analytics

How a single data strategy empowered Genomics England to sequence the future of British healthcare.

It was called one of the greatest feats of exploration in history. From its beginnings in 1993 to its completion in 2000, the project to map the human genome aimed to empower humanity for the first time to read the blueprint for how human beings are built.

Since the genome was finally mapped, organisations around the world have started to use that capability to improve how they provide healthcare to their citizens.

Take patients with rare diseases or cancers. In the past, they would endure long journeys to diagnose what was wrong with them and what they could treat it with. The approach was primarily based on trial and error, and the journey would often be unsuccessful. The result was a system that cost a significant amount of time and money for health services and provided mixed results for increasingly frustrated patients.

By sequencing the genomes of patients with these conditions, as well as their families, we can move toward a greater understanding both of diagnosis and treatment for people all around the world.

Dr Anna Need Quote - Genomics

You can view the full article by Telstra on 2 Apr 2020 at: https://purple.telstra.com/case-studies/genomics-england-case-study

Related Insights

How the pandemic has put data in demand

Disruption is always there, looming before any organisation. Whether it’s planned moments of change, or industry-shifting events beyond the…

Learn more
Learn more

Why a robust Security Culture starts with people

A strong security culture can go a long way in helping businesses increase their cyber resilience to internal and external threats, even mor…

Learn more
Learn more

Putting a spotlight on Cyber Security

In this issue of Business Chief Europe, our Telstra Purple team expand on the topic and importance of cyber resilience during Covid-19 and how organisations can get their cyber security right. This issue features invaluable insights from Manoj Bhatt and Rob Robinson amongst others.

Learn more
Learn more